Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1973-05-01
1979-02-06
Marantz, Sidney
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 232306, 424 12, 210 31C, 210504, 422 58, 422101, G01N 3316, A61K 4300
Patent
active
041384741
ABSTRACT:
A method and device for immunological determinations wherein the device comprises a container housing a volume of dry, insoluble, yet highly hydrophilic, gel particles, containing binding protein or combinations of binding protein and radio-active tag material and in which the dry gel particles are characterized by pores of a size that permit entry of low molecular weight components into the intra gel volume but insufficient to permit entry of large molecular weight components which remain in the extra gel volume.
REFERENCES:
patent: 3105012 (1963-09-01), Brandon et al.
patent: 3215500 (1965-11-01), Bittner
patent: 3451777 (1969-06-01), DiGiulio
patent: 3616936 (1971-11-01), Johansson et al.
patent: 3711247 (1973-01-01), Adams
patent: 3793445 (1974-02-01), Updike et al.
patent: 3794467 (1974-02-01), Adams et al.
patent: 3802843 (1974-04-01), Kim
Bernfeld, Science, v. 142, pp. 678-679, (1963).
Hicks et al., Analytical Chemistry, v. 38, pp. 726-730, (1966).
Chem. Abstr., v. 73: 127610m (1970).
Chem. Abstr., v. 74: 123000k (1971).
Chem. Abstr., v. 75: 33018p (1971).
Marantz Sidney
Wisconsin Alumni Research Foundation
LandOfFree
Method and device for immunoassay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and device for immunoassay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and device for immunoassay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-891576